News and Events
ABC Members Featured Among Faculty for the Masters of Medicine 2026 Conference in Jamaica
ABC Members Featured Among Faculty for the Masters of Medicine 2026 Conference in Jamaica The Masters of Medicine 2026 Conference will take place January 16–18, 2026, at the AC Hotel Kingston in Jamaica, bringing together leading experts, innovators, and healthcare professionals from around the world. Centered on the theme “Bridging the Divide: Tackling Obesity and Genetic Heart Disease in [...]
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
AstraZeneca today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access their prescribed medications at a transparent cash price with home delivery. AstraZeneca Direct will support people living with chronic conditions such as asthma, diabetes, heart failure and chronic kidney disease, and people seeking flu protection. [...]
LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS
THOUSAND OAKS, Calif., Oct. 2, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Phase 3 VESALIUS-CV clinical trial met its dual primary endpoints demonstrating that Repatha® (evolocumab) significantly reduced the risk of major adverse cardiovascular events (MACE) in individuals without a prior history of heart attack or stroke. The landmark Phase 3 VESALIUS-CV trial enrolled over 12,000 high-risk patients, [...]
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
Voluntary agreement meets the President’s four requests while also protecting the U.S. ecosystem responsible for America’s leadership in delivering medical breakthroughs.
BridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025
PALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one late breaking clinical trials oral presentation, one oral presentation, and three poster sessions will be shared at the Heart Failure Society of America (HFSA) Annual Scientific [...]
The Policy Pulse Summit: Driving Cardiovascular Health Equity
The ABC Third Annual Policy Pulse Summit will bring together leaders across healthcare, government, industry, advocacy, and community coalitions to advance policy-driven solutions that close gaps in cardiovascular access, treatment, and prevention. This year's agenda will explore challenges such as cardiology deserts, access to evidence-based therapies, and the role of technology and trusted messengers in improving early detection [...]
Upcoming Events
ABC at AHA Scientific Sessions 2025
November 7 - November 10Masters of Medicine 2026 Conference in Jamaica
January 16, 2026 - January 18, 20266th Annual National Sarasota Congress on Cardiovascular Disease Prevention
February 6, 2026 - February 7, 2026